Premium
Replication trial of omega‐3s shows no effect in preventing psychosis
Publication year - 2017
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30211
Subject(s) - psychosis , placebo , randomized controlled trial , replication (statistics) , psychiatry , medicine , early psychosis , clinical trial , alternative medicine , virology , pathology
A randomized clinical trial involving more than 300 patients has found no benefit from omega‐3 polyunsaturated fatty acids in conjunction with cognitive therapy in preventing onset of psychotic illness in at‐risk young adults. The trial, results of which were published online Nov. 23, 2016, in JAMA Psychiatry , failed to replicate results of an earlier study indicating that omega‐3s were superior to placebo in reducing the risk of transition to psychosis.